AMY W SCHULMAN
CIK 1438226 · Former Exec. Vice President · last filed 2026-05-22
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$15.58M
Companies
14
Total Filings
106
Lifetime Open-Market Net
$64.31M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ALNY | Director | 24,049 | $282.85 | $6.80M | -$5.26M | 20 | 2026-05-22 |
| ELV | Director | 781 | $404.07 | $315.6K | -$7.5K | 3 | 2026-05-15 |
| GUTS | Director | 8,550 | $0.85 | $7.3K | $10.0K | 3 | 2025-06-13 |
| CAMP | 10%+ Owner | 112,193 | $4.19 | $470.1K | $60.00M | 1 | 2024-10-15 |
| SQZ Biotechnologies Co (SQZ) Delisted | Director | 216,664 | $0.43 | $94.2K | $4.04M | 7 | 2023-06-15 |
| Hudson Executive Investment Corp. II (HCIIW) Delisted | Director | — | $0.00 | — | $0 | 1 | 2021-04-14 |
| CYCN | Director | 29,143 | $3.25 | $94.7K | $10.02M | 4 | 2020-06-18 |
| IRWD | Director | 38,242 | $3.65 | $139.6K | $0 | 7 | 2019-04-03 |
| IRONWOOD PHARMACEUTICALS INC (IRWDV) Delisted | Director | 42,298 | — | — | $0 | 1 | 2019-03-19 |
| ASNS | Director | — | $0.08 | — | $0 | 3 | 2018-06-07 |
| BUFF | Director | 0 | $52.31 | $0 | $0 | 3 | 2018-04-24 |
| DNIB UNWIND, INC. (BIND) Delisted | Director | — | — | — | $0 | 2 | 2015-06-10 |
| PFE | Former Exec. Vice President | 280,380 | $26.21 | $7.35M | -$4.61M | 50 | 2014-01-02 |
| ZTS | Director | 5,000 | $79.57 | $397.8K | $130.0K | 1 | 2013-02-08 |
Recent Filings · Page 2 of 11
106 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-06-27 | ALNY | Mixed | — | -$924.7K | EDGAR |
| 2024-05-31 | ALNY | Mixed | +8,300 | -$1.22M | EDGAR |
| 2024-05-20 | ALNY | Grant (A) | — | $0 | EDGAR |
| 2024-02-05 | GUTS | Grant (A) | — | $0 | EDGAR |
| 2023-06-15 | SQZ Biotechnologies Co (SQZ) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-05-19 | ALNY | Grant (A) | — | $0 | EDGAR |
| 2023-02-27 | ALNY | Exer (M) | +136 | $0 | EDGAR |
| 2022-06-16 | SQZ Biotechnologies Co (SQZ) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-05-20 | ALNY | Grant (A) | — | $0 | EDGAR |
| 2022-02-25 | ALNY | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.